Literature DB >> 29653227

RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children.

Jue Tang1, Wei Liu1, Jinhong Zhu2, Jiao Zhang3, Feng-Hua Wang1, Jiang-Hua Liang1, Jia-Hang Zeng1, Hui Wang1, Huimin Xia4, Jing He5.   

Abstract

Two new neuroblastoma susceptibility loci at 3q25 (RSRC1 rs6441201 G > A) and 4p16 (CPZ rs3796725 T > C and rs3796727 A > G) were identified by a genome-wide association study (GWAS) involving Italians, African Americans and European Americans. In this case-control study with 393 neuroblastoma cases and 812 controls, we investigated the association between these three polymorphisms and neuroblastoma susceptibility in Chinese population. We found that participants harboring the RSRC1 rs6441201A allele were associated with an increased risk of neuroblastoma (AA vs. GG: adjusted OR = 1.55, 95% CI = 1.03-2.34, P = 0.036). No significant association between the CPZ polymorphisms (rs3796725 T > C and rs3796727A > G) and neuroblastoma susceptibility was observed. In conclusion, our results confirm that the RSRC1 rs6441201A allele is associated with neuroblastoma susceptibility in Chinese population.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CPZ; Neuroblastoma; Polymorphism; RSRC1; Susceptibility

Mesh:

Substances:

Year:  2018        PMID: 29653227     DOI: 10.1016/j.gene.2018.04.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  1 in total

1.  RSRC1 loss-of-function variants cause mild to moderate autosomal recessive intellectual disability.

Authors:  Marcello Scala; Majid Mojarrad; Saima Riazuddin; Karlla W Brigatti; Zineb Ammous; Julie S Cohen; Heba Hosny; Muhammad A Usmani; Mohsin Shahzad; Sheikh Riazuddin; Valentina Stanley; Atiye Eslahi; Richard E Person; Hasnaa M Elbendary; Anne M Comi; Laura Poskitt; Vincenzo Salpietro; Queen Square Genomics; Jill A Rosenfeld; Katie B Williams; Dana Marafi; Fan Xia; Marta Biderman Waberski; Maha S Zaki; Joseph Gleeson; Erik Puffenberger; Henry Houlden; Reza Maroofian
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.